ALB and neoplasm: Systemic inflammatory and immunonutritional biomarkers, including the hemoglobin-albumin-lymphocyte-platelet (HALP) score, systemic immune-inflammation index (SII), and lymphocyte-to-monocyte ratio (LMR), may reflect host-tumor interactions.